GCM1 and fetal growth restriction: Future studies carefully characterizing the placenta tissues, the disease course and other biomarkers are required to clarify whether GCM1 enables stratification of IUGR subgroups and whether post-translational modifications of GCM1 are more suitable than total expression levels for diagnostic purposes.